Short Courses

Monday June 17, 2019

Morning | 9:00 am-12:00 pm

Introduction of GRCR-Based Drug Discovery


Annette Gilchrist, PhD, Professor, Pharmacology, Midwestern University

Afternoon | 1:30-4:30 pm

Optimizing Drug Metabolism, Drug Clearance and Drug-Drug Interactions (Tanuja)


Zhengyin Yan, PhD, Principal Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech Inc.

Donglu Zhang, PhD, Principal Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech Inc.

CNS Translational Strategies


Changning Wang, PhD, Assistant Professor, Radiology, Massachusetts General Hospital, Harvard Medical School

Dinner| 5:30-8:30 pm

Advanced Bioprinting Strategies for Generation of 3D Tissue Models - click here for more details


Yu Shrike Zhang, PhD, Assistant Professor & Associate Bioengineer, Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

Ricky Solorzano, CEO, Allevi, Inc.

Taciana Pereira, Director, Bioengineering, Allevi, Inc.

Applications of Artificial Intelligence & Machine Learning in Drug Discovery & Development


Arvind Rao, PhD, Associate Professor, Department of Computational Medicine and Bioinformatics, The University of Michigan, Ann Arbor

Deepak K. Rajpal, Senior Scientific Director, GSK R&D

Additional Instructors to be Announced

Targeted Protein Degradation Using PROTACS and Molecular Glues


Davide Gianni, PhD, Associate Director, Discovery Sciences, AstraZeneca

Additional Instructors to be Announced

Fit-for-Purpose Biomarker Assay Development and Validation


John L. Allinson, FIBMS, Vice President, Biomarker Services, Biologics Development Services, Tampa Bay

Viswanath Devanarayan, PhD, Global Head of Statistics & Data Sciences, Charles River Laboratories

Wednesday June 19, 2019

Dinner| 6:15-9:15 pm

Practical Phenotypic Screening


Fabien Vincent, PhD, Associate Research Fellow, Hit Discovery and Lead Profiling Group, Pfizer

Kristin Rockwell, PhD, Senior Scientist, Discovery Sciences, Pfizer

Evaluating and Characterizing in vitro Models of Drug Toxicity


Terry Van Vleet, PhD, DABT, Head of Molecular and Computational Toxicology, Department of Preclinical Safety, Abbvie  

William Proctor, PhD, DABT, Associate Director/Senior Scientist, Investigative Toxicology, Department of Safety Assessment, Genentech Inc.

In vitro and in vivo Modeling for Cancer Immunotherapy


Michael Brehm, PhD, Associate Professor, The Robert and Sandra Glass Term Chair in Diabetes, Diabetes Center of Excellence, Program in Molecular Medicine, University of Massachusetts Medical School

Additional Instructors to be Announced

*Separate registration required.